Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bruno, M. K.
Right arrow Articles by Ptácek, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bruno, M. K.
Right arrow Articles by Ptácek, L.
Related Collections
Right arrow All Movement Disorders
Right arrow Chorea
Right arrow All Genetics
NEUROLOGY 2007;68:1782-1789
© 2007 American Academy of Neurology

Genotype–phenotype correlation of paroxysmal nonkinesigenic dyskinesia

M. K. Bruno, MD, H.-Y Lee, PhD, G.W.J. Auburger, MD, A. Friedman, MD, J. E. Nielsen, MD, PhD, A. E. Lang, MD, E. Bertini, MD, P. Van Bogaert, MD, Y. Averyanov, MD, M. Hallett, MD, K. Gwinn-Hardy, MD, B. Sorenson, M. Pandolfo, H. Kwiecinski, MD, S. Servidei, MD, Y.-H Fu, PhD and L. Ptácek, MD

From the Department of Neurology, University of California, San Francisco, CA (M.K.B., H.-Y.L., B.S., Y.-H.F., L.P.); National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD (M.K.B., M.H., K.G.-H.); J.W. Goethe University Hospital, Frankfurt, Germany (G.W.J.A.); Department of Neurology, Medical Academy of Warsaw, Warsaw, Poland (A.F., H.K.); Institute of Medical Biochemistry & Genetics, The Panum Institute, University of Copenhagen, Copenhagen, Denmark (J.E.N.); University of Toronto, Toronto Canada (A.E.L.); Department of Neurosciences, Bambino Gesu’ Research Hospital, IRCCS, Rome, Italy (E.B.); Erasme Hospital, Brussels, Belgium (P.V.B., M.P.); Clinic of Nervous Disease, Moscow Medical Academy, Moscow, Russia (Y.A.); Institute of Neurology, Catholic University, Rome, Italy (S.S.); and Howard Hughes Medical Institute, University of California, San Francisco, CA (L.P.).

Address correspondence and reprint requests to Dr. Louis J. Ptácek, Howard Hughes Medical Institute, Department of Neurology, University of California, San Francisco, CA 94158

Background: Paroxysmal nonkinesigenic dyskinesia (PNKD) is a rare disorder characterized by episodic hyperkinetic movement attacks. We have recently identified mutations in the MR-1 gene causing familial PNKD.

Methods: We reviewed the clinical features of 14 kindreds with familial dyskinesia that was not clearly induced by movement or during sleep. Of these 14 kindreds, 8 had MR-1 mutations and 6 did not.

Results: Patients with PNKD with MR-1 mutations had their attack onset in youth (infancy and early childhood). Typical attacks consisted of a mixture of chorea and dystonia in the limbs, face, and trunk, and typical attack duration lasted from 10 minutes to 1 hour. Caffeine, alcohol, and emotional stress were prominent precipitants. Attacks had a favorable response to benzodiazepines, such as clonazepam and diazepam. Attacks in families without MR-1 mutations were more variable in their age at onset, precipitants, clinical features, and response to medications. Several were induced by persistent exercise.

Conclusions: Paroxysmal nonkinesigenic dyskinesia (PNKD) should be strictly defined based on age at onset and ability to precipitate attacks with caffeine and alcohol. Patients with this clinical presentation (which is similar to the phenotype initially reported by Mount and Reback) are likely to harbor myofibrillogenesis regulator 1 (MR-1) gene mutations. Other "PNKD-like" families exist, but atypical features suggests that these subjects are clinically distinct from PNKD and do not have MR-1 mutations. Some may represent paroxysmal exertional dyskinesia.


Received July 13, 2006. Accepted in final form January 18, 2007.




This article has been cited by other articles:


Home page
J. Med. Genet.Home page
J Rochette, P Roll, and P Szepetowski
Genetics of infantile seizures with paroxysmal dyskinesia: the infantile convulsions and choreoathetosis (ICCA) and ICCA-related syndromes
J. Med. Genet., December 1, 2008; 45(12): 773 - 779.
[Abstract] [Full Text] [PDF]


Home page
Therapeutic Advances in Neurological DisordersHome page
I. Unterberger and E. Trinka
Review: Diagnosis and treatment of paroxysmal dyskinesias revisited
Therapeutic Advances in Neurological Disorders, September 1, 2008; 1(2): 67 - 74.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by AAN Enterprises, Inc.